Antisense nucleic acids

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9890381
SERIAL NO

15339069

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a pharmaceutical agent which causes skipping of the 55th, 45th, 50th or 44th exon in the human dystrophin gene with a high efficiency. The present invention provides an oligomer which efficiently enables to cause skipping of the 55th, 45th, 50th or 44th exon in the human dystrophin gene.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NIPPON SHINYAKU CO LTD14 KISSHOIN NISHINOSHO MONGUCHICHO MINAMI-KU KYOTO-SHI KYOTO 6018550 ?6018550
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY4-1-1 OGAWAHIGASHI-CHO KODAIRA-SHI TOKYO 1878551 ?1878551

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nagata, Tetsuya Tokyo, JP 155 1907
Seo, Haruna Tokyo, JP 8 164
Takeda, Shin'ichi Tokyo, JP 44 503
Watanabe, Naoki Ibaraki, JP 375 4361

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00